Form EFFECT Lyra Therapeutics, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 26, 2026 |
| Accession Number: | 0001193125-26-124474 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Inventus Power Launches the LV-24V50, a Compact 24V Lithium-ion Battery for Next-Generation Robotics and Material Handling
- Fortune Media and Great Place To Work Name CareChoice to 2026 Best Workplaces for Women List, Ranking No. 23
- MEDIA ALERT: TechCrunch Publishes Article on SMX's Digital Material Identity Technology
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share